Webcast: Precision Medicine Approach to Cancer Care and Prevention

Event Information

Share this event

Date and Time

Event description

Description

Kinexum and Cello Health BioConsulting (previously Defined Health) will be holding a public webcast featuring Brian Leyland-Jones, MB, BS, PhD, Vice President of Molecular and Experimental Research at the Avera Cancer Institute, and Jeffrey Bockman, PhD, Executive Vice President, Oncology Practice Head, at Cello Health BioConsulting (previously Defined Health) on the successes and challenges of precision medicine in cancer care and prevention.


Click here to RSVP and obtain log-in information

In case of further inquiries, please email jenniferzhao@kinexum.com


Cancer has traditional been clinically described and treated as an organ-specific disease. Only within the past year or two has the FDA approved tissue-agnostic tumor therapies based on the underlying molecular pathways of the disease.

With the price of tumor sequencing collapsing on its way down to hundreds, rather than thousands, of dollars, Brian Leyland-Jones, MB, BS, PhD, Vice President of Molecular and Experimental Medicine at Avera Cancer Institute, previously affiliated with Stanford, Cornell, McGill, Emory, Memorial Sloan-Kettering, and NCI, argues that not sequencing tumors will constitute medical malpractice within several years, and cancer should generally be treated aggressively by cocktails of therapies indicated or suggested by periodic sequencing, to shut down tumor growth and metastases.

Beyond treatment, it is conceptually possible that in the future, regular physicals will include screening for blood markers that can direct cancer to be nipped in the bud before it can be otherwise diagnosed.

However, challenges remain for expanding access to these improving treatment and prevention modalities: additional targeted therapies and biomarkers will need to be developed for multiple molecular pathways; regulatory approvals, medical practice guidelines and reimbursement policies lag, in some cases years, behind the science and medicine.

Please join Dr. Leyland-Jones and Jeffrey Bockman, PhD, EVP, Oncology Practice Head at Cello Health BioConsulting, organizers of the annual thought-leading Cancer Progress conferences, for a “fireside chat” on some astounding latest successes in cancer treatment and some complex challenges.

Date and Time

Save This Event

Event Saved